PSTV

#3614
PLUS THERAPEUTICS, Inc. Common Stock
0.30
0.00%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
0.30
0.30
Jahresspanne
0.16
2.29
Tagesänderung
0.00%
Monatliche Änderung
+25.00%
6 month change
-40.00%
Jahresänderung
-55.88%
Vorheriger Schlusskurs
0.30
Open
0.30
Bid
Ask
Low
0.30
High
0.30
Volumen
7
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
  • Market Capitalization 32.23 M
  • Employee 21
  • Founded 1996
  • CEO N/A
  • Website www.plustherapeutics.com
  • Headquarter Delaware, United States
  • FIGI BBG000C1Z086
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.49
Price to sales ratio
1.52
Dividends per share
—
Dividend yield %
—

PLUS THERAPEUTICS Inc

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

Nachrichten